{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:50:12Z","timestamp":1793998212410,"version":"4.8.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100019304","name":"Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019304","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019305","name":"Manipal Academy of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019305","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.seizure.2022.09.011","type":"journal-article","created":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T09:17:28Z","timestamp":1663406248000},"page":"36-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Role of human leukocyte antigen in anti-epileptic drugs-induced Stevens\u2013Johnson Syndrome\/toxic epidermal necrolysis: A meta-analysis"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6390-7764","authenticated-orcid":false,"given":"Muhammed","family":"Rashid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8523-7968","authenticated-orcid":false,"given":"Asha K","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manik","family":"Chhabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananth","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viji Pulikkel","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6218-9617","authenticated-orcid":false,"given":"Rajesh","family":"Venkataraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreedharan","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1257-969X","authenticated-orcid":false,"given":"Girish","family":"Thunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.seizure.2022.09.011_bib0001","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.0013-9580.2004.455005.x","article-title":"The use of antiepileptic drugs\u2014principles and practice","volume":"45","author":"Sander","year":"2004","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.seizure.2022.09.011_bib0002","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/ijd.14411","article-title":"Valproic acid and Stevens\u2013Johnson syndrome: a systematic review of descriptive studies","volume":"58","author":"Rashid","year":"2019","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.seizure.2022.09.011_bib0003","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.seizure.2020.01.002","article-title":"Levetiracetam and cutaneous adverse reactions: a systematic review of descriptive studies","volume":"75","author":"Rashid","year":"2020","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.seizure.2022.09.011_bib0004","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1528-1157.1978.tb04506.x","article-title":"Antiepileptic drug development: I. History and a program for progress","volume":"19","author":"Krall","year":"1978","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.seizure.2022.09.011_bib0005","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1528-1167.2011.03024.x","article-title":"Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma","volume":"52","author":"L\u00f6scher","year":"2011","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.seizure.2022.09.011_bib0006","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/1346-8138.13430","article-title":"Severe cutaneous adverse drug reactions","volume":"43","author":"Chung","year":"2016","journal-title":"J Dermatol"},{"issue":"5","key":"10.1016\/j.seizure.2022.09.011_bib0007","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/iji.12443","article-title":"Factors affecting HLA expression: a review","volume":"46","author":"Carey","year":"2019","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.seizure.2022.09.011_bib0008","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3389\/fphar.2020.00969","article-title":"Pharmacogenetic testing for prevention of severe cutaneous adverse drug reactions","volume":"11","author":"Chang","year":"2020","journal-title":"Front Pharmacol"},{"issue":"12","key":"10.1016\/j.seizure.2022.09.011_bib0009","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1111\/epi.14599","article-title":"Temporal trends and patterns in carbamazepine use, related severe cutaneous adverse reactions, and HLA-B*15:02 screening: a nationwide study","volume":"59","author":"Lin","year":"2018","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.seizure.2022.09.011_bib0010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/FPC.0000000000000021","article-title":"HLA alleles and hypersensitivity to carbamazepine: an updated systematic review with meta-analysis","volume":"24","author":"Grover","year":"2014","journal-title":"Pharmacogenet Genom"},{"key":"10.1016\/j.seizure.2022.09.011_bib0011","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.phrs.2016.11.027","article-title":"Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS\/TEN are different from those found for the same AED-induced DRESS in the Spanish population","volume":"115","author":"Ram\u00edrez","year":"2017","journal-title":"Pharmacol Res"},{"issue":"5","key":"10.1016\/j.seizure.2022.09.011_bib0012","doi-asserted-by":"crossref","first-page":"555","DOI":"10.4168\/aair.2018.10.5.555","article-title":"The Fas signaling pathway is a common genetic risk factor for severe cutaneous drug adverse reactions across diverse drugs","volume":"10","author":"Park","year":"2018","journal-title":"Allergy Asthma Immunol Res"},{"issue":"6982","key":"10.1016\/j.seizure.2022.09.011_bib0013","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens\u2013Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.seizure.2022.09.011_bib0014","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":"HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.seizure.2022.09.011_bib0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jdermsci.2013.10.003","article-title":"Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations","volume":"73","author":"Hsiao","year":"2014","journal-title":"J Dermatol Sci"},{"issue":"1","key":"10.1016\/j.seizure.2022.09.011_bib0016","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1212\/WNL.0000000000003453","article-title":"Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians","volume":"88","author":"Chen","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2022.09.011_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2780272","article-title":"Association between HLA-B alleles and carbamazepine-induced maculopapular exanthema and severe cutaneous reactions in Thai patients","volume":"2018","author":"Sukasem","year":"2018","journal-title":"J Immunol Res"},{"issue":"2\u20133","key":"10.1016\/j.seizure.2022.09.011_bib0018","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.eplepsyres.2010.10.006","article-title":"Association study of lamotrigine-induced cutaneous adverse reactions and HLA-B*1502 in a Han Chinese population","volume":"92","author":"An","year":"2010","journal-title":"Epilepsy Res"},{"issue":"1\u20132","key":"10.1016\/j.seizure.2022.09.011_bib0019","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.eplepsyres.2013.05.004","article-title":"Predictive markers for carbamazepine and lamotrigine-induced maculopapular exanthema in Han Chinese","volume":"106","author":"Li","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2022.09.011_bib0020","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3389\/fphar.2017.00879","article-title":"Association of HLA-A and HLA-B alleles with lamotrigine-induced cutaneous adverse drug reactions in the Thai population","volume":"8","author":"Koomdee","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.seizure.2022.09.011_bib0021","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.seizure.2019.02.011","article-title":"Association of cutaneous adverse drug reactions due to antiepileptic drugs with HLA alleles in a North Indian population","volume":"66","author":"Ihtisham","year":"2019","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.seizure.2022.09.011_bib0022","doi-asserted-by":"crossref","first-page":"87","DOI":"10.14581\/jer.16016","article-title":"Spectrum of cutaneous adverse reactions to Levetiracetam and human leukocyte antigen typing in North-Indian patients","volume":"6","author":"Ramanujam","year":"2016","journal-title":"J Epilepsy Res"},{"issue":"52","key":"10.1016\/j.seizure.2022.09.011_bib0023","doi-asserted-by":"crossref","first-page":"e23929","DOI":"10.1097\/MD.0000000000023929","article-title":"HLA-A\u221724:02 associated with lamotrigine-induced cutaneous adverse drug reactions: a systematic review and meta-analysis","volume":"99","author":"Li","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.seizure.2022.09.011_bib0024","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/cpt.1493","article-title":"Shared genetic risk factors across carbamazepine-induced hypersensitivity reactions","volume":"106","author":"Nicoletti","year":"2019","journal-title":"Clin Pharm Ther"},{"key":"10.1016\/j.seizure.2022.09.011_bib0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.seizure.2018.06.024","article-title":"Association between HLA alleles and lamotrigine-induced cutaneous adverse drug reactions in Asian populations: a meta-analysis","volume":"60","author":"Deng","year":"2018","journal-title":"Seizure"},{"issue":"5","key":"10.1016\/j.seizure.2022.09.011_bib0026","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.neurol.2017.11.006","article-title":"The HLA-B*15:02 polymorphism and Tegretol(\u00ae)-induced serious cutaneous reactions in epilepsy: an updated systematic review and meta-analysis","volume":"174","author":"Chouchi","year":"2018","journal-title":"Rev Neurol"},{"issue":"1","key":"10.1016\/j.seizure.2022.09.011_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18433\/J36S7D","article-title":"Association between HLA genotypes and oxcarbazepine-induced cutaneous adverse drug reactions: a systematic review and meta-analysis","volume":"21","author":"Tangamornsuksan","year":"2018","journal-title":"J Pharm Pharm Sci"},{"issue":"6","key":"10.1016\/j.seizure.2022.09.011_bib0028","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2217\/pgs-2017-0189","article-title":"Association between HLA-B*15:02 and oxcarbazepine-induced cutaneous adverse reaction: a meta-analysis","volume":"19","author":"Liu","year":"2018","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.seizure.2022.09.011_bib0029","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.eplepsyres.2017.05.015","article-title":"Association between the HLA-B alleles and carbamazepine-induced SJS\/TEN: a meta-analysis","volume":"135","author":"Wang","year":"2017","journal-title":"Epilepsy Res"},{"issue":"23","key":"10.1016\/j.seizure.2022.09.011_bib0030","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1212\/WNL.0000000000004008","article-title":"HLA-A*24:02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactions","volume":"88","author":"Shi","year":"2017","journal-title":"Neurol"},{"issue":"2","key":"10.1016\/j.seizure.2022.09.011_bib0031","first-page":"107","article-title":"HLA-B*1502 increases the risk of phenytoin or lamotrigine induced Stevens\u2013Johnson Syndrome\/toxic epidermal necrolysis: evidence from a meta-analysis of nine case-control studies","volume":"65","author":"Li","year":"2015","journal-title":"Drug Res"},{"key":"10.1016\/j.seizure.2022.09.011_bib0032","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1750-1172-6-52","article-title":"Genome-wide association study of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Europe","volume":"6","author":"G\u00e9nin","year":"2011","journal-title":"Orphanet J Rare Dis"},{"issue":"2\u20133","key":"10.1016\/j.seizure.2022.09.011_bib0033","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12016-014-8418-y","article-title":"Genetics of immune-mediated adverse drug reactions: a comprehensive and clinical review","volume":"48","author":"Yip","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.seizure.2022.09.011_bib0034","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.seizure.2022.09.011_bib0035","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010403","article-title":"Empirical evaluation of the Q-Genie tool: a protocol for assessment of effectiveness","volume":"6","author":"Sohani","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.seizure.2022.09.011_bib0036","unstructured":"Centre T.N.C. Review Manager 5.3. 5.3 ed. UK: the Cochrane Collaboration; 2014."},{"key":"10.1016\/j.seizure.2022.09.011_bib0037","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.seizure.2022.09.011_bib0038","doi-asserted-by":"crossref","unstructured":"Borenstein M. Comprehensive meta-analysis software. Systematic Reviews in Health Research: meta-Analysis in Context. 2022:535\u201348.","DOI":"10.1002\/9781119099369.ch27"},{"key":"10.1016\/j.seizure.2022.09.011_bib0039","doi-asserted-by":"crossref","unstructured":"Sterne J., Egger M., Moher D.J., Afwhco. Chapter 10: addressing reporting biases in: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. 2008.","DOI":"10.1002\/9780470712184.ch10"},{"issue":"18","key":"10.1016\/j.seizure.2022.09.011_bib0040","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2217\/pgs-2017-0103","article-title":"Association of the HLA-B alleles with carbamazepine-induced Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotype","volume":"18","author":"Yuliwulandari","year":"2017","journal-title":"Pharmacogenomics"},{"issue":"1","key":"10.1016\/j.seizure.2022.09.011_bib0041","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/jcpt.12754","article-title":"Drug-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database: a subgroup approach to disproportionality analysis","volume":"44","author":"Nguyen","year":"2019","journal-title":"J Clin Pharm Ther"},{"issue":"7","key":"10.1016\/j.seizure.2022.09.011_bib0042","first-page":"16","article-title":"Association between HLA-B*15:02 allele and antiepileptic drug-induced severe cutaneous reactions in Hong Kong Chinese: a population-based study","volume":"20","author":"Kwan","year":"2014","journal-title":"Hong Kong Med J"},{"issue":"5","key":"10.1016\/j.seizure.2022.09.011_bib0043","first-page":"1256","article-title":"Association between the HLA-B*15:02 allele and carbamazepine-induced Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis in Han individuals of northeastern China","volume":"65","author":"He","year":"2013","journal-title":"Pharmacol Res"},{"issue":"7","key":"10.1016\/j.seizure.2022.09.011_bib0044","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/epi.12217","article-title":"HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese","volume":"54","author":"Cheung","year":"2013","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.seizure.2022.09.011_bib0045","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/clpt.2013.55","article-title":"HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children","volume":"94","author":"Amstutz","year":"2013","journal-title":"Clin Pharm Ther"},{"issue":"1","key":"10.1016\/j.seizure.2022.09.011_bib0046","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1742-7843.2012.00868.x","article-title":"Association between HLA and Stevens\u2013Johnson syndrome induced by carbamazepine in Southern Han Chinese: genetic markers besides B*1502?","volume":"111","author":"Shi","year":"2012","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"10.1016\/j.seizure.2022.09.011_bib0047","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jdermsci.2013.04.013","article-title":"HLA-B*58:01 strongly associates with allopurinol-induced adverse drug reactions in a Japanese sample population","volume":"71","author":"Niihara","year":"2013","journal-title":"J Dermatol Sci"},{"issue":"5","key":"10.1016\/j.seizure.2022.09.011_bib0048","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1528-1167.2010.02533.x","article-title":"Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population","volume":"51","author":"Tassaneeyakul","year":"2010","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.seizure.2022.09.011_bib0049","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1111\/epi.12802","article-title":"HLA-B*15:02 association with carbamazepine-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in an Indian population: a pooled-data analysis and meta-analysis","volume":"55","author":"Khor","year":"2014","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.seizure.2022.09.011_bib0050","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1528-1167.2008.01719.x","article-title":"Carbamazepine and phenytoin induced Stevens\u2013Johnson syndrome is associated with HLA-B*1502 allele in Thai population","volume":"49","author":"Locharernkul","year":"2008","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.seizure.2022.09.011_bib0051","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00228-017-2250-2","article-title":"Influence of genetic and non-genetic factors on phenytoin-induced severe cutaneous adverse drug reactions","volume":"73","author":"Yampayon","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.seizure.2022.09.011_bib0052","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/epi.13509","article-title":"Association of HLA genotypes with phenobarbital hypersensitivity in children","volume":"57","author":"Manuyakorn","year":"2016","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.seizure.2022.09.011_bib0053","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/FPC.0000000000000211","article-title":"Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population","volume":"26","author":"Tassaneeyakul","year":"2016","journal-title":"Pharmacogenet Genom"},{"issue":"2","key":"10.1016\/j.seizure.2022.09.011_bib0054","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/tpj.2016.10","article-title":"Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population","volume":"17","author":"Chang","year":"2017","journal-title":"Pharmacogenomics J"},{"issue":"7","key":"10.1016\/j.seizure.2022.09.011_bib0055","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/FPC.0000000000000287","article-title":"HLA-A*31: 01 and HLA-B*15:02 association with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis to carbamazepine in a multiethnic Malaysian population","volume":"27","author":"Khor","year":"2017","journal-title":"Pharmacogenet Genom"},{"issue":"2","key":"10.1016\/j.seizure.2022.09.011_bib0056","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-4632.2010.04745.x","article-title":"Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens\u2013Johnson syndrome in the multi-ethnic Malaysian population","volume":"50","author":"Chang","year":"2011","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.seizure.2022.09.011_bib0057","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2217\/pgs.09.162","article-title":"Common risk allele in aromatic antiepileptic-drug induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Han Chinese","volume":"11","author":"Hung","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.seizure.2022.09.011_bib0058","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.yebeh.2014.05.025","article-title":"Genetic predictors of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis induced by aromatic antiepileptic drugs among the Chinese Han population","volume":"37","author":"Wang","year":"2014","journal-title":"Epilepsy Behav"},{"issue":"15","key":"10.1016\/j.seizure.2022.09.011_bib0059","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2217\/pgs.13.180","article-title":"Japan Pharmacogenomics Data Science Consortium. Specific HLA types are associated with antiepileptic drug-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Japanese subjects","volume":"14","author":"Kaniwa","year":"2013","journal-title":"Pharmacogenomics"},{"issue":"8","key":"10.1016\/j.seizure.2022.09.011_bib0060","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2217\/pgs-2020-0191","article-title":"HLA-A*24:07 as a potential biomarker for carbamazepine-induced Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis in Filipino patients","volume":"22","author":"Capule","year":"2021","journal-title":"Pharmacogenomics"},{"issue":"8","key":"10.1016\/j.seizure.2022.09.011_bib0061","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3390\/jpm11080737","article-title":"Association of HLA-B*51:01, HLA-B*55:01, CYP2C9*3, and phenytoin-induced cutaneous adverse drug reactions in the South Indian Tamil population","volume":"11","author":"John","year":"2021","journal-title":"J Pers Med"},{"issue":"1","key":"10.1016\/j.seizure.2022.09.011_bib0062","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2217\/pgs-2019-0146","article-title":"Genetic susceptibilities and prediction modeling of carbamazepine and allopurinol-induced severe cutaneous adverse reactions in Vietnamese","volume":"22","author":"van Nguyen","year":"2021","journal-title":"Pharmacogenomics"},{"issue":"5","key":"10.1016\/j.seizure.2022.09.011_bib0063","doi-asserted-by":"crossref","first-page":"e15393","DOI":"10.1111\/dth.15393","article-title":"Association between human leukocyte antigens and cutaneous adverse drug reactions to antiepileptics and antibiotics in the Iranian population","volume":"35","author":"Mortazavi","year":"2022","journal-title":"Dermatol Ther"},{"issue":"B","key":"10.1016\/j.seizure.2022.09.011_bib0064","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3889\/oamjms.2020.4906","article-title":"The link between HLA-B alleles and causative drugs in Vietnamese patients with Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis","volume":"8","author":"Huyen","year":"2020","journal-title":"Open Access Maced J Med Sci"},{"issue":"11","key":"10.1016\/j.seizure.2022.09.011_bib0065","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/all.13821","article-title":"RegiSCAR group. HLA-B*57:01 confers genetic susceptibility to carbamazepine-induced SJS\/TEN in Europeans","volume":"74","author":"Mockenhaupt","year":"2019","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.seizure.2022.09.011_bib0066","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41397-019-0143-8","article-title":"Association of carbamazepine-induced Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis with the HLA-B75 serotype or HLA-B*15:21 allele in Filipino patients","volume":"20","author":"Capule","year":"2020","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.seizure.2022.09.011_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2020.106321","article-title":"Association of HLA genotypes with phenytoin induced severe cutaneous adverse drug reactions in Thai children","volume":"162","author":"Manuyakorn","year":"2020","journal-title":"Epilepsy Res"},{"issue":"2","key":"10.1016\/j.seizure.2022.09.011_bib0068","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/exd.14240","article-title":"Investigating the association of lamotrigine and phenytoin-induced Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis with HLA-B*1502 in Iranian population","volume":"30","author":"Sabourirad","year":"2021","journal-title":"Exp Dermatol"},{"issue":"2","key":"10.1016\/j.seizure.2022.09.011_bib0069","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/bcp.15022","article-title":"Genetic variants associated with severe cutaneous adverse drug reactions induced by carbamazepine","volume":"88","author":"Nakkam","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.seizure.2022.09.011_bib0070","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1528-1167.2007.01022.x","article-title":"Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese","volume":"48","author":"Man","year":"2007","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.seizure.2022.09.011_bib0071","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4103\/0972-2327.104338","article-title":"Antiepileptic drugs prescription utilization behavior and direct costs of treatment in a national hospital of India","volume":"15","author":"Haroon","year":"2012","journal-title":"Ann Indian Acad Neruol"},{"issue":"2","key":"10.1016\/j.seizure.2022.09.011_bib0072","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1684\/j.1950-6945.2004.tb00053.x","article-title":"Antiepileptic drugs: indications other than epilepsy","volume":"6","author":"Spina","year":"2004","journal-title":"Epileptic Disord"},{"issue":"5","key":"10.1016\/j.seizure.2022.09.011_bib0073","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2710.2002.00429.x","article-title":"Drug utilization pattern of anti-epileptic drugs: a pharmacoepidemiologic study in Oman","volume":"27","author":"Hanssens","year":"2002","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"10.1016\/j.seizure.2022.09.011_bib0074","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11910-009-0048-z","article-title":"Epilepsy in the developing world","volume":"9","author":"Carpio","year":"2009","journal-title":"Curr Neurol Neurosci Res"},{"issue":"1","key":"10.1016\/j.seizure.2022.09.011_bib0075","first-page":"42","article-title":"Antiepileptic drugs-induced Stevens\u2013Johnson syndrome: a case Series","volume":"8","author":"Trivedi","year":"2016","journal-title":"J Basic Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.seizure.2022.09.011_bib0076","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.tpj.6500356","article-title":"A marker for Stevens\u2013Johnson syndrome...: ethnicity matters","volume":"6","author":"Lonjou","year":"2006","journal-title":"Pharmacogenomics J"},{"issue":"4","key":"10.1016\/j.seizure.2022.09.011_bib0077","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions","volume":"16","author":"Hung","year":"2006","journal-title":"Pharmacogenet Genom"},{"issue":"5","key":"10.1016\/j.seizure.2022.09.011_bib0078","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.seizure.2011.01.005","article-title":"Phenytoin-induced Stevens\u2013Johnson syndrome with negative HLA-B*1502 allele in mainland China: two cases","volume":"20","author":"Hu","year":"2011","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.seizure.2022.09.011_bib0079","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ccr3.1288","article-title":"Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis associated with zonisamide","volume":"6","author":"Vivar","year":"2017","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.seizure.2022.09.011_bib0080","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.567048","article-title":"Diagnostic test criteria for HLA genotyping to prevent drug hypersensitivity reactions: a systematic review of actionable HLA recommendations in CPIC and DPWG guidelines","volume":"11","author":"Manson","year":"2020","journal-title":"Front Pharmacol"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131122002035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131122002035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T02:01:51Z","timestamp":1761012111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131122002035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":80,"alternative-id":["S1059131122002035"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2022.09.011","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of human leukocyte antigen in anti-epileptic drugs-induced Stevens\u2013Johnson Syndrome\/toxic epidermal necrolysis: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2022.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}